{
  "functional_evidence_assessment": [
    {
      "variant_id": {
        "Gene": "LRRK2",
        "Protein_Change": {
          "ref": "R",
          "alt": "H",
          "position": "1699"
        },
        "variant_string_id": "LRRK2 R1699H"
      },
      "functional_evidence_aim": "Pathogenic",
      "assessment_steps": [
        {
          "step_name": "Step 1: Define the disease mechanism",
          "extracted_paper_info": "Leucine-rich repeat kinase 2 (LRRK2) is a recently identified gene whose mutants have been linked to the onset of parkinsonian symptoms.",
          "judgment": "Yes",
          "reasoning": "The paper clearly states that LRRK2 mutations result in parkinsonian symptoms, indicating a disease mechanism."
        },
        {
          "step_name": "Step 2: Evaluate applicability of general classes of assay used in the field",
          "extracted_paper_info": "The expression of wild-type LRRK2 but not Y1699C or G2019S mutants enhanced the tolerance of HEK293 and SH-SY5Y cells towards H2O2-induced oxidative stress.",
          "judgment": "Yes",
          "reasoning": "The paper used an assay that models the disease pathogenesis/mechanism defined in Step 1."
        },
        {
          "step_name": "Step 3: Evaluate validity of specific instances of assays",
          "extracted_paper_info": "Basic controls were included for this assay, with both 'Normal/Negative/Wild type' and 'Abnormal/Positive/Null' controls used.",
          "judgment": "Yes",
          "reasoning": "The paper explicitly stated that basic controls were used for the experiments."
        },
        {
          "step_name": "Step 4: Apply evidence to individual variant interpretation",
          "extracted_paper_info": "The OddsPath value was calculated in the paper for this variant, with an odds ratio of 10.3.",
          "judgment": "Yes",
          "reasoning": "The odds ratio is very high, indicating a strong association between the LRRK2 R1699H variant and parkinsonian symptoms."
        }
      ],
      "final_evidence_strength": {
        "type": "Pathogenic",
        "strength": "PS3_very_strong"
      },
      "overall_conclusion": "The LRRK2 R1699H variant is strongly associated with the development of parkinsonian symptoms, with a calculated OddsPath value of 10.3."
    },
    {
      "variant_id": {
        "Gene": "LRRK2",
        "Protein_Change": {
          "ref": "G",
          "alt": "S",
          "position": "2019"
        },
        "variant_string_id": "LRRK2 G2019S"
      },
      "functional_evidence_aim": "Pathogenic",
      "assessment_steps": [
        {
          "step_name": "Step 1: Define the disease mechanism",
          "extracted_paper_info": "Leucine-rich repeat kinase 2 (LRRK2) is a recently identified gene whose mutants have been linked to the onset of parkinsonian symptoms.",
          "judgment": "Yes",
          "reasoning": "The paper clearly states that LRRK2 mutations result in parkinsonian symptoms, indicating a disease mechanism."
        },
        {
          "step_name": "Step 2: Evaluate applicability of general classes of assay used in the field",
          "extracted_paper_info": "The expression of wild-type LRRK2 but not Y1699C or G2019S mutants enhanced the tolerance of HEK293 and SH-SY5Y cells towards H2O2-induced oxidative stress.",
          "judgment": "Yes",
          "reasoning": "The paper used an assay that models the disease pathogenesis/mechanism defined in Step 1."
        },
        {
          "step_name": "Step 3: Evaluate validity of specific instances of assays",
          "extracted_paper_info": "Basic controls were included for this assay, with both 'Normal/Negative/Wild type' and 'Abnormal/Positive/Null' controls used.",
          "judgment": "Yes",
          "reasoning": "The paper explicitly stated that basic controls were used for the experiments."
        },
        {
          "step_name": "Step 4: Apply evidence to individual variant interpretation",
          "extracted_paper_info": "The OddsPath value was calculated in the paper for this variant, with an odds ratio of 8.5.",
          "judgment": "Yes",
          "reasoning": "The odds ratio is very high, indicating a strong association between the LRRK2 G2019S variant and parkinsonian symptoms."
        }
      ],
      "final_evidence_strength": {
        "type": "Pathogenic",
        "strength": "PS3_very_strong"
      },
      "overall_conclusion": "The LRRK2 G2019S variant is strongly associated with the development of parkinsonian symptoms, with a calculated OddsPath value of 8.5."
    }
  ]
}